🇺🇸 FDA
Patent

US 10676442

Salt derivative of tetrahydroisoquinoline and crystalline thereof and preparation method therefore and application thereof

granted A61KA61K31/472A61P

Quick answer

US patent 10676442 (Salt derivative of tetrahydroisoquinoline and crystalline thereof and preparation method therefore and application thereof) held by China State Institute of Pharmaceutical Industry expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China State Institute of Pharmaceutical Industry
Grant date
Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/472, A61P, A61P9/06